openPR Logo
Press release

Key Insights of Global Diverticular Disease Therapeutics Market Covering Prime Factors and Competitive Outlook Till 2028 || Top Growing Industries- Shire, Cook Group Incorporated, Allergen, Salix Pharmaceuticals, novoGI, SCLNOW BIOTECHNOLOGY CO.LTD., Sand

12-24-2018 07:52 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

Diverticular disease commonly occurs in people age above 40 years and the prevalence is increasing over the time. Approximately 10% of people over age 40 and 50% of people over age 60 encounter diverticular disease at some point in time. The disease was first identified in the 1930s, to share many of the hallmarks of inflammatory bowel disease. Diverticular disease is characterized by formation of small bulge or sacks called diverticula in the wall of colon. The sigmoid colon is more prone to formation of diverticula. These sacks may range from pea-size to much larger. The disease is associated with symptoms such as pain, bloating,

Get Free Sample Report here @ https://www.factmr.com/connectus/sample?flag=S&rep_id=930

nausea, diarrhea or constipation. Many of these symptoms are similar to inflammatory bowel disease. 20% of the patients may develop severe complications of diverticular disease such as abdominal or rectal bleeding. Diverticular disease are of three types viz. symptomatic uncomplicated diverticular disease, recurrent symptomatic diverticular disease and complicated diverticular disease. Standard treatment recommended for diverticular disease includes antibiotic therapies. Mesalazine (Asacol) and rifaximin (Xifaxan) are commonly recommended antibiotics for diverticular disease. Alternative therapies such as probiotics and diet modification may provide symptomatic relief and prevent recurrence, but are recommended along with standard antibiotics. There are two stages of diverticular disease viz. diverticulosis (presence of diverticula without complications) and diverticulitisan (inflammatory condition caused by perforation of the diverticula). Surgical treatment may be required in case of acute and recurrent diverticulitis.

Diverticular Disease Therapeutics Market: Drivers and Restraints

The growing prevalence and recurrence of diverticular disease is expected to be the major factor driving the growth of the diverticular disease therapeutics market over the forecast period. According to the World Journal of Gastrointestinal Pharmacology and Therapeutics, the prevalence of diverticular disease has increased from 35% to 50% in the last three decades. Changes is lifestyle and eating habits are attributed to growing prevalence of diverticular disease. Launch and addition of new therapies is the other factor contributing to the growth of the global diverticular disease therapeutics market. For instance, Cook Group Incorporated is evaluating Hemospray device in phase 2 clinical trial to control colonic bleeding in severe diverticular disease. Shire Plc. is evaluating SPD476 and SPD476 MMX in phase 3 clinical trial to reduce recurrence of diverticulitis.

Diverticular Disease Therapeutics Market: Segmentation

Tentatively, the global diverticular disease therapeutics market can be segmented on the basis of treatment, indication, distribution channel, and geography.

Based on treatment, the global diverticular disease therapeutics market is segmented as:

Antibiotics Treatment
Symptomatic Treatment

Based on indications, the global diverticular disease therapeutics market is segmented as:

Symptomatic Uncomplicated Diverticular Disease
Recurrent Symptomatic Diverticular Disease
Complicated Diverticular Disease.

Based on distribution channel, the global diverticular disease therapeutics market is segmented as:

Hospital Pharmacy
Retail Pharmacies
Drug Stores
Online Pharmacy
Others

To know more about the Diverticular Disease Therapeutics Market Trends, Visit the link – https://www.factmr.com/report/930/diverticular-disease-therapeutics-market

Diverticular Disease Therapeutics Market: Overview

The global market for diverticular disease therapeutics is expected to witness moderate growth over the forecast period. Majority of the antibiotics are introduced in the generic market and thus there exists a high competition among local and regional players. Among the two treatment types, the antibiotic treatment segment is expected to lead in the global diverticular disease therapeutics market over the forecast period. Retail pharmacy distribution channel is expected to contribute high share in the global diverticular disease therapeutics market as it is the most accessible channel and majority of patients are recommended for outpatient treatment.

Diverticular Disease Therapeutics Market: Regional Outlook

Geographically, the global diverticular disease therapeutics market is segmented into viz. North America, Latin America, Europe, Asia-Pacific excluding Japan (APEJ), Japan and the Middle East and Africa (MEA). North America is expected to be dominant market in the global diverticular disease therapeutics market owing to high prevalence of the disease. The diverticular disease therapeutics market in Asia Pacific excluding Japan is expected to grow at a significant CAGR due to expansion of product offerings by the key players. Europe is expected to have second large share in the global diverticular disease therapeutics market throughout the forecast period.

Diverticular Disease Therapeutics Market: Key Players

The global market for diverticular disease therapeutics is highly fragmented. Examples of some of the key players operating in the global diverticular disease therapeutics market are Shire Plc., Cook Group Incorporated, Allergen Plc., Salix Pharmaceuticals Inc. novoGI, Inc., SCLNOW BIOTECHNOLOGY CO.,LTD., Sandoz (Novartis AG), Glaxosmithkline Inc., Pfizer Inc., Gilead Sciences, Inc., and Fresenius Kabi AG, among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil)
Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, Rest Of MEA)

Diverticular Disease Therapeutics Market Report is available for Pre-booking @ https://www.factmr.com/checkout/949/S

About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Read Industry News at- https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Key Insights of Global Diverticular Disease Therapeutics Market Covering Prime Factors and Competitive Outlook Till 2028 || Top Growing Industries- Shire, Cook Group Incorporated, Allergen, Salix Pharmaceuticals, novoGI, SCLNOW BIOTECHNOLOGY CO.LTD., Sand here

News-ID: 1457377 • Views: 927

More Releases from Fact.MR

11-09-2020 | Health & Medicine
Fact.MR
PCR and Real-time PCR Molecular Diagnostics Market to Surpass US$ 6 Bn by 2030, …
As per data from the World Health Organization, millions of deaths can be attributed to diseases such as cancer and HIV each year. Further, the recent outbreak of the COVID-19 virus has also created massive demand for effective diagnostics processes. The PCR and real-time PCR molecular diagnostics market has been gaining traction in recent years on the back of investments by PCR diagnostic test manufacturers towards the incorporation of molecular
10-05-2020 | Health & Medicine
Fact.MR
Biobanking Market to Soar to US$ 3.5 Bn by 2027, Notes Fact.MR
Biobanks are a type of repository which is used in the storage of biological samples, including human and animal tissues, which primarily find use in research applications. Consequently, the process of biobanking has become a very important part of medical research and has played a major role in modern science fields such as personalized medications, and genomics. The global biobanking market is expected to grow at a healthy CAGR of ~
Mini LED Market to Expand 7.5X by 2030, Finds New Study by Fact.MR
In recent years, increasing popularity of OLED TVs in China and India has been significantly influencing growth of the mini LED market. With an increase in disposable income of a majority of the population in these countries, the inclination towards smart screens with higher lifespan and better performance is expected to open up numerous growth opportunities for the mini LED market. Moreover, aspiring and affluent households have increased their spending
Uncertainty Surrounding COVID-19 to Shave-off Growth in Electrical Steel Market …
The global electrical steel market has utilized the opportunities in the market over the last decade with sales of electrical steel pegged at US$ 20.4 Bn in 2019. However, sales are set to plummet during in the middle two quarters of 2020 owing to COVID-19. In addition, several automakers have shuttered their production units, causing incalculable loss to the electrical steel market in 2020. However, the demand of electrical steel

All 5 Releases


More Releases for Diverticular

Diverticular Disease Market Expected to Grow 7.5% CAGR with Sucampo Pharmaceutic …
Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period. Market Scenario: Diverticular disease is a digestive condition that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular disease can be caused by many factors such as low fiber
Diverticular Disease Market 2023 Top Key Players are Sucampo Pharmaceuticals, In …
Market Research Future has added a report titled “Diverticular Disease Market Research Report - Forecast to 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period. Market Scenario: Diverticular disease is a digestive condition
Diverticular Disease Market 2023 Top Key Players are Sucampo Pharmaceuticals, In …
Market Research Future has added a report titled “Diverticular Disease Market Research Report - Forecast to 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period. Market Scenario: Diverticular disease is a digestive condition
Diverticular Disease Market 2023 Top Key Players are Sucampo Pharmaceuticals, In …
Market Research Future has added a report titled “Diverticular Disease Market Research Report - Forecast to 2023” to its offering. The report provides an in-depth analysis of regional data and an accurate projection of the market size and share of the Top 10 market players across the globe. Global Diverticular disease market is expected to grow at a CAGR of 7.5% during the forecast period. Market Scenario: Diverticular disease is a digestive condition
Diverticular Disease Therapeutics Market - Latest Trends and Key Drivers Support …
Diverticular disease commonly occurs in people age above 40 years and the prevalence is increasing over the time. Approximately 10% of people over age 40 and 50% of people over age 60 encounter diverticular disease at some point in time. The disease was first identified in the 1930s, to share many of the hallmarks of inflammatory bowel disease. Diverticular disease is characterized by formation of small bulge or sacks called
Diverticular Disease Market 2023 Top Key Players Sucampo Pharmaceuticals, Inc., …
Global Diverticular Disease Market is expected to grow at a CAGR of 7.5% during the forecast period. Market Scenario: Diverticular disease is a digestive condition that leads to the formation of sacs or small bulges in the wall of the large intestine. These sacs can be formed anywhere in the colon, but it is majorly found in the sigmoid colon. Diverticular disease can be caused by many factors such as low fiber